FLNA
Price
$1.24
Change
+$0.04 (+3.33%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
59.42M
32 days until earnings call
Intraday BUY SELL Signals
TCRT
Price
$2.08
Change
-$0.09 (-4.15%)
Updated
Jul 2, 04:51 PM (EDT)
Capitalization
5.08M
Intraday BUY SELL Signals
Interact to see
Advertisement

FLNA vs TCRT

FLNA vs TCRT Comparison Chart in %
View a ticker or compare two or three
VS
FLNA vs. TCRT commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLNA is a Hold and TCRT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (FLNA: $1.20 vs. TCRT: $2.08)
Brand notoriety: FLNA and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FLNA: 92% vs. TCRT: 89%
Market capitalization -- FLNA: $59.42M vs. TCRT: $5.08M
FLNA [@Biotechnology] is valued at $59.42M. TCRT’s [@Biotechnology] market capitalization is $5.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLNA’s FA Score shows that 1 FA rating(s) are green whileTCRT’s FA Score has 0 green FA rating(s).

  • FLNA’s FA Score: 1 green, 4 red.
  • TCRT’s FA Score: 0 green, 5 red.
According to our system of comparison, FLNA is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLNA’s TA Score shows that 3 TA indicator(s) are bullish while TCRT’s TA Score has 5 bullish TA indicator(s).

  • FLNA’s TA Score: 3 bullish, 4 bearish.
  • TCRT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TCRT is a better buy in the short-term than FLNA.

Price Growth

FLNA (@Biotechnology) experienced а +3.45% price change this week, while TCRT (@Biotechnology) price change was +0.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

FLNA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FLNA($59.4M) has a higher market cap than TCRT($5.08M). TCRT YTD gains are higher at: -35.604 vs. FLNA (-39.394). TCRT has higher annual earnings (EBITDA): -4.13M vs. FLNA (-81.75M). FLNA has more cash in the bank: 86.6M vs. TCRT (354K). TCRT has higher revenues than FLNA: TCRT (3K) vs FLNA (0).
FLNATCRTFLNA / TCRT
Capitalization59.4M5.08M1,169%
EBITDA-81.75M-4.13M1,979%
Gain YTD-39.394-35.604111%
P/E RatioN/AN/A-
Revenue03K-
Total Cash86.6M354K24,463%
Total DebtN/A0-
FUNDAMENTALS RATINGS
FLNA vs TCRT: Fundamental Ratings
FLNA
TCRT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8587
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FLNA's Valuation (31) in the Pharmaceuticals Other industry is somewhat better than the same rating for TCRT (77) in the Biotechnology industry. This means that FLNA’s stock grew somewhat faster than TCRT’s over the last 12 months.

FLNA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TCRT (100) in the Biotechnology industry. This means that FLNA’s stock grew similarly to TCRT’s over the last 12 months.

FLNA's SMR Rating (99) in the Pharmaceuticals Other industry is in the same range as TCRT (100) in the Biotechnology industry. This means that FLNA’s stock grew similarly to TCRT’s over the last 12 months.

FLNA's Price Growth Rating (85) in the Pharmaceuticals Other industry is in the same range as TCRT (87) in the Biotechnology industry. This means that FLNA’s stock grew similarly to TCRT’s over the last 12 months.

FLNA's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as TCRT (100) in the Biotechnology industry. This means that FLNA’s stock grew similarly to TCRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FLNATCRT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FLNA
Daily Signal:
Gain/Loss:
TCRT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDE17.300.76
+4.59%
Coeur Mining
TTEC2.05N/A
N/A
TTEC Holdings
TWAV1.30N/A
N/A
TaoWeave Inc.
PFS23.54-0.43
-1.79%
Provident Financial Services
BHB37.66-0.97
-2.51%
Bar Harbor Bankshares

FLNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLNA has been loosely correlated with RXRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FLNA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLNA
1D Price
Change %
FLNA100%
N/A
RXRX - FLNA
44%
Loosely correlated
N/A
EDIT - FLNA
43%
Loosely correlated
N/A
PRME - FLNA
42%
Loosely correlated
N/A
CRBU - FLNA
41%
Loosely correlated
N/A
SANA - FLNA
38%
Loosely correlated
N/A
More